INJ holds in upper recent range supported by Robinhood listing: weekly forecast

Traders Union
All News
Crypto
Injective gains 7.05% this week

Highlights

INJ maintains a medium-term bullish structure above key support but faces notable long-term resistance overhead.
Momentum indicators are mixed, showing recent buyer strength but signaling fading conviction and a weak overall trend.
Expected trading range for the next week is $4.65 to $6.09, with risks balanced between bullish breakout and renewed selling.

Regulatory advances and listings drive institutional sentiment this week

Injective advanced its regulatory and institutional presence with the publication of a MiCA whitepaper in the interim ESMA register and a filing for SEC Transfer Agent registration. The INJ token was listed on Robinhood, and Coinbase began its mainnet migration, temporarily pausing related deposits and withdrawals. Injective also became a founding member of the x402 Foundation under the Linux Foundation, joining major global organizations. The team further expanded its ecosystem by launching an AI Agent SDK for on-chain AI application development.

Mixed momentum as INJ tests resistance amid weak trend signals

Weekly technical signals are mixed, with INJ holding above its MA-20 but under important resistance at the MA-50 and MA-200. The MACD points to ongoing selling pressure, and the ADX at 19.49 shows a lack of trend strength. Meanwhile, the RSI at 53.05 and CCI at 68.50 signal mild bullish momentum, but Stochastic RSI is neutral and Bull/Bear Power is slightly overbought at 0.66. Key weekly support sits near $4.65, with resistance around $6.09, reinforced by the current price position within the upper range and a weekly volatility of 13.90%.

Sideways scenario favored as range persists and indicators split

For the next 7 days, INJ is likely to trade sideways between $4.65 and $6.09 as buyers and sellers reach an equilibrium. If momentum shifts back to the bulls, a breakout above $6.09 could be seen, but failure to sustain recent buying may push the price below $4.65. With a 50% probability of moving in either direction and only half of weekly indicators supportive, a range-bound scenario remains the base case.

Jainam Mehta, market strategist, notes that Injective maintained its position above its weekly MA-20 while still facing resistance at the MA-50 and MA-200 during the past week. He observes regulatory and institutional momentum from new listings and filings, but sees technical signals as mixed with limited trend strength and only mild bullish momentum. According to Mehta, price action reflects a battle between buyers and sellers, with the most likely scenario being sideways movement between $4.65 and $6.09 in the coming week. "With upside capped by major averages and only half the indicators supportive, I expect range-bound price action until a decisive momentum shift emerges."

Earlier, analysts noted that Injective was displaying strong bullish momentum, with technical signals favoring continued upside. While near-term price action has moved further into the upper trading range, the current equilibrium between buyers and sellers introduces heightened breakout risk, so traders should monitor for a decisive move above resistance or below support in the days ahead.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.